1)Gurram MM:Effect of posterior sub-tenon triamcinolone in macular edema due to non-ischemic vein occlusion. J Clin Diagn Res 7:2821-2824, 2013
2)神尾聡美・山本禎子・三浦 瞳・他:網膜静脈分枝閉塞症に対する硝子体手術およびトリアムシノロン硝子体内投与の短期効果についての検討.あたらしい眼科 28:287-292,2011
3)多田英司・高木 均・王 英泰・他:網膜静脈閉塞症の黄斑浮腫に対する格子状光凝固の光干渉断層装置による検討.臨眼 56:1439-1442,2002
4)Sato T, Sawada K, Iwahashi-Shima C et al:25-gauge Vitrectomy versus intervitreal bevacizumab for macular edema secondary to branch retinal vein occlusion. Ann Acad Med Singapore 41:294-299, 2012
5)寺島浩子・長谷部日・高田律子・他:網膜静脈分枝閉塞症に対するbevacizumab硝子体内投与の視力予後.眼科手術 26:289-293,2013
6)加藤睦子・中山 正・熊瀬有美・他:網膜静脈分枝閉塞症に伴う黄斑浮腫へのベバシズマブ硝子体内投与.臨眼 63:683-687,2009
7)古瀬 悠・大野京子・土屋 香・他:網膜静脈分枝閉塞症に伴う黄斑浮腫に対するbevacizumab硝子体内投与の有効性—1年での検討.眼臨紀 3:908-912,2010
8)Hanada N. Iijima H. Sakurada Y et al:Recurrence of macular edema associated with branch retinal vein occulusion after intravitreal bevacizumab. Jpn J Ophthalmol 56:165-174, 2012
9)Campochiaro PA, Heier JS, Feiner L et al:Ranibizumab for macular edema following branch retinal vein occlusion:six-month primary end point results of a phase Ⅲ study. Ophthalmology 117:1102-1112, 2010
10)Campochiaro PA, Sophie R, Pearlman J et al:Long-term outcomes in patients with retinal vein occlusion treated with ranibizumab:the RETAIN study. Ophthalmology 121:209-219, 2014
11)Sophie R, Hafiz G, Scott AW et al:Long-term outcomes in ranibizumab-treated patients with retinal vein occlusion;the role of progression of retinal nonperfusion. Am J Ophthalmol 156:693-705, 2013
12)Gallego-Pinazo R, Dolz-Marco R, Pardo-López D et al:Ranibizumab for serous macular detachment in branch retinal vein occlusions. Graefes Arch Clin Exp Ophthalmol 251:9-14, 2013
13)松崎有修・土至田宏・武田淳史・他:網膜静脈分枝閉塞症に伴う黄斑浮腫に対するベバシズマブ3回投与の治療効果.眼科手術 26:653-657,2013
14)Murakami T, Tsujikawa A, Miyamoto K et al:Disrupted foveal photoreceptors after combined cystoid spaces and retinal detachment in branch vein occlusion treated with bevacizumab. Retina 32:1853-1861, 2012